Sign In

Login

Password

Forgot Password ? Sign Up

Opioidrezeptoren (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Opioidrezeptoren" in German language version.

refsWebsite
Global rank German rank
39nih.gov
4th place
7th place
36doi.org
2nd place
3rd place

doi.org

  • Corbett AD, Henderson G, McKnight AT, Paterson SJ: 75 years of opioid research: the exciting but vain quest for the Holy Grail. In: Br J Pharmacol. 147 Suppl 1. Jahrgang, Suppl 1, 2006, S. S153–62, doi:10.1038/sj.bjp.0706435, PMID 16402099, PMC 1760732 (freier Volltext).
  • Beckett AH, Casy AF: Synthetic analgesics: stereochemical considerations. In: J Pharm Pharmacol. 6. Jahrgang, Nr. 12, 1954, S. 986–1001, doi:10.1111/j.2042-7158.1954.tb11033.x, PMID 13212680.
  • Pasternak GW, Pan YX: Mu opioids and their receptors: evolution of a concept. In: Pharmacol Rev. 65. Jahrgang, Nr. 4, 2013, S. 1257–317, doi:10.1124/pr.112.007138, PMID 24076545, PMC 3799236 (freier Volltext).
  • Pert CB, Snyder SH: Opiate receptor: demonstration in nervous tissue. In: Science. 179. Jahrgang, Nr. 4077, 1973, S. 1011–4, doi:10.1126/science.179.4077.1011, PMID 4687585.
  • Dietis N, Rowbotham DJ, Lambert DG: Opioid receptor subtypes: fact or artifact? In: Br J Anaesth. 107. Jahrgang, Nr. 1, Juli 2011, S. 8–18, doi:10.1093/bja/aer115, PMID 21613279.
  • Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR: Identification of two related pentapeptides from the brain with potent opiate agonist activity. In: Nature. 258. Jahrgang, Nr. 5536, 1975, S. 577–80, doi:10.1038/258577a0, PMID 1207728.
  • Fricker LD, Margolis EB, Gomes I, Devi LA: Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions. In: Mol Pharmacol. 98. Jahrgang, Nr. 2, 2020, S. 96–108, doi:10.1124/mol.120.119388, PMID 32487735, PMC 7330675 (freier Volltext).
  • Lord JA, Waterfield AA, Hughes J, Kosterlitz HW: Endogenous opioid peptides: multiple agonists and receptors. In: Nature. 267. Jahrgang, Nr. 5611, 1977, S. 495–9, doi:10.1038/267495a0, PMID 195217.
  • Evans CJ, Keith DE, Morrison H, Magendzo K, Edwards RH: Cloning of a delta opioid receptor by functional expression. In: Science. 258. Jahrgang, Nr. 5090, 1992, S. 1952–5, doi:10.1126/science.1335167, PMID 1335167.
  • Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H: Cloning and pharmacological characterization of a rat kappa opioid receptor. In: Proc Natl Acad Sci U S A. 90. Jahrgang, Nr. 21, 1993, S. 9954–8, doi:10.1073/pnas.90.21.9954, PMID 8234341, PMC 47691 (freier Volltext).
  • Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC: ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. In: FEBS Lett. 341. Jahrgang, Nr. 1, 1994, S. 33–8, doi:10.1016/0014-5793(94)80235-1, PMID 8137918.
  • Befort K, Mattéi MG, Roeckel N, Kieffer B: Chromosomal localization of the delta opioid receptor gene to human 1p34.3-p36.1 and mouse 4D bands by in situ hybridization. In: Genomics. 20. Jahrgang, Nr. 1, 1994, S. 143–5, doi:10.1006/geno.1994.1146, PMID 8020949.
  • Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR: Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. In: FEBS Lett. 338. Jahrgang, Nr. 2, 1994, S. 217–22, doi:10.1016/0014-5793(94)80368-4, PMID 7905839.
  • Yasuda K, Espinosa R, Takeda J, Le Beau MM, Bell GI: Localization of the kappa opioid receptor gene to human chromosome band 8q11.2. In: Genomics. 19. Jahrgang, Nr. 3, 1994, S. 596–7, doi:10.1006/geno.1994.1117, PMID 8188308.
  • Bare LA, Mansson E, Yang D: Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. In: FEBS Lett. 354. Jahrgang, Nr. 2, 1994, S. 213–6, doi:10.1016/0014-5793(94)01129-x, PMID 7957926.
  • Cox BM, Christie MJ, Devi L, Toll L, Traynor JR: Challenges for opioid receptor nomenclature: IUPHAR Review 9. In: Br J Pharmacol. 172. Jahrgang, Nr. 2, 2015, S. 317–23, doi:10.1111/bph.12612, PMID 24528283, PMC 4292949 (freier Volltext).
  • Toll L, Bruchas MR, Calo' G, Cox BM, Zaveri NT: Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems. In: Pharmacol Rev. 68. Jahrgang, Nr. 2, 2016, S. 419–57, doi:10.1124/pr.114.009209, PMID 26956246, PMC 4813427 (freier Volltext).
  • Dreborg S, Sundström G, Larsson TA, Larhammar D: Evolution of vertebrate opioid receptors. In: Proc Natl Acad Sci U S A. 105. Jahrgang, Nr. 40, 2008, S. 15487–92, doi:10.1073/pnas.0805590105, PMID 18832151, PMC 2563095 (freier Volltext).
  • Stevens CW, Brasel CM, Mohan S: Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals. In: Neurosci Lett. 419. Jahrgang, Nr. 3, 2007, S. 189–94, doi:10.1016/j.neulet.2007.04.014, PMID 17452077, PMC 3075437 (freier Volltext).
  • Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC: Structure of the human κ-opioid receptor in complex with JDTic. In: Nature. 485. Jahrgang, Nr. 7398, 2012, S. 327–32, doi:10.1038/nature10939, PMID 22437504, PMC 3356457 (freier Volltext).
  • Kane BE, Svensson B, Ferguson DM: Molecular recognition of opioid receptor ligands. In: AAPS J. 8. Jahrgang, Nr. 1, 2006, S. E126–37, doi:10.1208/aapsj080115, PMID 16584119, PMC 2751431 (freier Volltext).
  • Meunier J, Mouledous L, Topham CM: The nociceptin (ORL1) receptor: molecular cloning and functional architecture. In: Peptides. 21. Jahrgang, Nr. 7, 2000, S. 893–900, doi:10.1016/s0196-9781(00)00225-4, PMID 10998522.
  • Beispiel: O’Brien ES, Rangari VA, El Daibani A, Eans SO, Hammond HR, White E, Wang H, Shiimura Y, Krishna Kumar K, Jiang Q, Appourchaux K, Huang W, Zhang C, Kennedy BJ, Mathiesen JM, Che T, McLaughlin JP, Majumdar S, Kobilka BK: A µ-opioid receptor modulator that works cooperatively with naloxone. In: Nature. 631. Jahrgang, Nr. 8021, 2024, S. 686–693, doi:10.1038/s41586-024-07587-7, PMID 38961287.
  • Beispiel: Kaneko S, Imai S, Uchikubo-Kamo T, Hisano T, Asao N, Shirouzu M, Shimada I: Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator. In: Nat Commun. 15. Jahrgang, Nr. 1, 2024, S. 3544, doi:10.1038/s41467-024-47792-6, PMID 38740791, PMC 11091225 (freier Volltext).
  • Piltonen M, Krokhotin A, Parisien M, Bérubé P, Djambazian H, Sladek R, Dokholyan NV, Shabalina SA, Diatchenko L: Alternative Splicing of Opioid Receptor Genes Shows a Conserved Pattern for 6TM Receptor Variants. In: Cell Mol Neurobiol. 41. Jahrgang, Nr. 5, 2021, S. 1039–1055, doi:10.1007/s10571-020-00971-7, PMID 33010019, PMC 8159799 (freier Volltext).
  • Piltonen M, Parisien M, Grégoire S, Chabot-Doré AJ, Jafarnejad SM, Bérubé P, Djambazian H, Sladek R, Geneau G, Willett P, Stone LS, Shabalina SA, Diatchenko L: Alternative Splicing of the Delta-Opioid Receptor Gene Suggests Existence of New Functional Isoforms. In: Mol Neurobiol. 56. Jahrgang, Nr. 4, 2019, S. 2855–2869, doi:10.1007/s12035-018-1253-z, PMID 30066306.
  • Ugur M, Derouiche L, Massotte D: Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo. In: Front Pharmacol. 9. Jahrgang, 2018, S. 1240, doi:10.3389/fphar.2018.01240, PMID 30483121, PMC 6244869 (freier Volltext).
  • Zhang L, Zhang JT, Hang L, Liu T: Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective. In: Front Pharmacol. 11. Jahrgang, 2020, S. 1078, doi:10.3389/fphar.2020.01078, PMID 32760281, PMC 7373791 (freier Volltext).
  • Gaborit M, Massotte D: Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities. In: Br J Pharmacol. 180. Jahrgang, Nr. 7, 2023, S. 994–1013, doi:10.1111/bph.15772, PMID 34883528.
  • Cechova K, Lan C, Macik M, Barthes NPF, Jung M, Ulbrich MH: Kappa but not delta or mu opioid receptors form homodimers at low membrane densities. In: Cell Mol Life Sci. 78. Jahrgang, Nr. 23, 2021, S. 7557–7568, doi:10.1007/s00018-021-03963-y, PMID 34657173, PMC 8629795 (freier Volltext).
  • Li-Wei C, Can G, De-He Z, Qiang W, Xue-Jun X, Jie C, Zhi-Qiang C: Homodimerization of human mu-opioid receptor overexpressed in Sf9 insect cells. In: Protein Pept Lett. 9. Jahrgang, Nr. 2, 2002, S. 145–52, doi:10.2174/0929866023408850, PMID 12141912.
  • Fujita W, Gomes I, Devi LA: Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities. In: Br J Pharmacol. 172. Jahrgang, Nr. 2, 2015, S. 375–87, doi:10.1111/bph.12663, PMID 24571499, PMC 4292954 (freier Volltext).
  • Costantino CM, Gomes I, Stockton SD, Lim MP, Devi LA: Opioid receptor heteromers in analgesia. In: Expert Rev Mol Med. 14. Jahrgang, 2012, S. e9, doi:10.1017/erm.2012.5, PMID 22490239, PMC 3805500 (freier Volltext).
  • Remesic M, Hruby VJ, Porreca F, Lee YS: Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. In: ACS Chem Neurosci. 8. Jahrgang, Nr. 6, 2017, S. 1147–1158, doi:10.1021/acschemneuro.7b00090, PMID 28368571, PMC 5689070 (freier Volltext).
  • Han J, Zhang J, Nazarova AL, Bernhard SM, Krumm BE, Zhao L, Lam JH, Rangari VA, Majumdar S, Nichols DE, Katritch V, Yuan P, Fay JF, Che T: Ligand and G-protein selectivity in the κ-opioid receptor. In: Nature. 617. Jahrgang, Nr. 7960, 2023, S. 417–425, doi:10.1038/s41586-023-06030-7, PMID 37138078, PMC 10172140 (freier Volltext).
  • Lamberts JT, Jutkiewicz EM, Mortensen RM, Traynor JR: μ-Opioid receptor coupling to Gα(o) plays an important role in opioid antinociception. In: Neuropsychopharmacology. 36. Jahrgang, Nr. 10, 2011, S. 2041–53, doi:10.1038/npp.2011.91, PMID 21654736, PMC 3158321 (freier Volltext).

nih.gov

ncbi.nlm.nih.gov

  • Corbett AD, Henderson G, McKnight AT, Paterson SJ: 75 years of opioid research: the exciting but vain quest for the Holy Grail. In: Br J Pharmacol. 147 Suppl 1. Jahrgang, Suppl 1, 2006, S. S153–62, doi:10.1038/sj.bjp.0706435, PMID 16402099, PMC 1760732 (freier Volltext).
  • Beckett AH, Casy AF: Synthetic analgesics: stereochemical considerations. In: J Pharm Pharmacol. 6. Jahrgang, Nr. 12, 1954, S. 986–1001, doi:10.1111/j.2042-7158.1954.tb11033.x, PMID 13212680.
  • Martin WR: Opioid antagonists. In: Pharmacol Rev. 19. Jahrgang, Nr. 4, 1967, S. 463–521, PMID 4867058.
  • Pasternak GW, Pan YX: Mu opioids and their receptors: evolution of a concept. In: Pharmacol Rev. 65. Jahrgang, Nr. 4, 2013, S. 1257–317, doi:10.1124/pr.112.007138, PMID 24076545, PMC 3799236 (freier Volltext).
  • Pert CB, Snyder SH: Opiate receptor: demonstration in nervous tissue. In: Science. 179. Jahrgang, Nr. 4077, 1973, S. 1011–4, doi:10.1126/science.179.4077.1011, PMID 4687585.
  • Dietis N, Rowbotham DJ, Lambert DG: Opioid receptor subtypes: fact or artifact? In: Br J Anaesth. 107. Jahrgang, Nr. 1, Juli 2011, S. 8–18, doi:10.1093/bja/aer115, PMID 21613279.
  • Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR: Identification of two related pentapeptides from the brain with potent opiate agonist activity. In: Nature. 258. Jahrgang, Nr. 5536, 1975, S. 577–80, doi:10.1038/258577a0, PMID 1207728.
  • Fricker LD, Margolis EB, Gomes I, Devi LA: Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions. In: Mol Pharmacol. 98. Jahrgang, Nr. 2, 2020, S. 96–108, doi:10.1124/mol.120.119388, PMID 32487735, PMC 7330675 (freier Volltext).
  • Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE: The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. In: J Pharmacol Exp Ther. 197. Jahrgang, Nr. 3, 1976, S. 517–32, PMID 945347.
  • Lord JA, Waterfield AA, Hughes J, Kosterlitz HW: Endogenous opioid peptides: multiple agonists and receptors. In: Nature. 267. Jahrgang, Nr. 5611, 1977, S. 495–9, doi:10.1038/267495a0, PMID 195217.
  • Evans CJ, Keith DE, Morrison H, Magendzo K, Edwards RH: Cloning of a delta opioid receptor by functional expression. In: Science. 258. Jahrgang, Nr. 5090, 1992, S. 1952–5, doi:10.1126/science.1335167, PMID 1335167.
  • Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H: Cloning and pharmacological characterization of a rat kappa opioid receptor. In: Proc Natl Acad Sci U S A. 90. Jahrgang, Nr. 21, 1993, S. 9954–8, doi:10.1073/pnas.90.21.9954, PMID 8234341, PMC 47691 (freier Volltext).
  • Chen Y, Mestek A, Liu J, Hurley JA, Yu L: Molecular cloning and functional expression of a mu-opioid receptor from rat brain. In: Mol Pharmacol. 44. Jahrgang, Nr. 1, 1993, S. 8–12, PMID 8393525.
  • Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC: ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. In: FEBS Lett. 341. Jahrgang, Nr. 1, 1994, S. 33–8, doi:10.1016/0014-5793(94)80235-1, PMID 8137918.
  • Befort K, Mattéi MG, Roeckel N, Kieffer B: Chromosomal localization of the delta opioid receptor gene to human 1p34.3-p36.1 and mouse 4D bands by in situ hybridization. In: Genomics. 20. Jahrgang, Nr. 1, 1994, S. 143–5, doi:10.1006/geno.1994.1146, PMID 8020949.
  • Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR: Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. In: FEBS Lett. 338. Jahrgang, Nr. 2, 1994, S. 217–22, doi:10.1016/0014-5793(94)80368-4, PMID 7905839.
  • Yasuda K, Espinosa R, Takeda J, Le Beau MM, Bell GI: Localization of the kappa opioid receptor gene to human chromosome band 8q11.2. In: Genomics. 19. Jahrgang, Nr. 3, 1994, S. 596–7, doi:10.1006/geno.1994.1117, PMID 8188308.
  • Bare LA, Mansson E, Yang D: Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. In: FEBS Lett. 354. Jahrgang, Nr. 2, 1994, S. 213–6, doi:10.1016/0014-5793(94)01129-x, PMID 7957926.
  • Cox BM, Christie MJ, Devi L, Toll L, Traynor JR: Challenges for opioid receptor nomenclature: IUPHAR Review 9. In: Br J Pharmacol. 172. Jahrgang, Nr. 2, 2015, S. 317–23, doi:10.1111/bph.12612, PMID 24528283, PMC 4292949 (freier Volltext).
  • Toll L, Bruchas MR, Calo' G, Cox BM, Zaveri NT: Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems. In: Pharmacol Rev. 68. Jahrgang, Nr. 2, 2016, S. 419–57, doi:10.1124/pr.114.009209, PMID 26956246, PMC 4813427 (freier Volltext).
  • Dreborg S, Sundström G, Larsson TA, Larhammar D: Evolution of vertebrate opioid receptors. In: Proc Natl Acad Sci U S A. 105. Jahrgang, Nr. 40, 2008, S. 15487–92, doi:10.1073/pnas.0805590105, PMID 18832151, PMC 2563095 (freier Volltext).
  • Stevens CW, Brasel CM, Mohan S: Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals. In: Neurosci Lett. 419. Jahrgang, Nr. 3, 2007, S. 189–94, doi:10.1016/j.neulet.2007.04.014, PMID 17452077, PMC 3075437 (freier Volltext).
  • Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC: Structure of the human κ-opioid receptor in complex with JDTic. In: Nature. 485. Jahrgang, Nr. 7398, 2012, S. 327–32, doi:10.1038/nature10939, PMID 22437504, PMC 3356457 (freier Volltext).
  • Kane BE, Svensson B, Ferguson DM: Molecular recognition of opioid receptor ligands. In: AAPS J. 8. Jahrgang, Nr. 1, 2006, S. E126–37, doi:10.1208/aapsj080115, PMID 16584119, PMC 2751431 (freier Volltext).
  • Meunier J, Mouledous L, Topham CM: The nociceptin (ORL1) receptor: molecular cloning and functional architecture. In: Peptides. 21. Jahrgang, Nr. 7, 2000, S. 893–900, doi:10.1016/s0196-9781(00)00225-4, PMID 10998522.
  • Beispiel: O’Brien ES, Rangari VA, El Daibani A, Eans SO, Hammond HR, White E, Wang H, Shiimura Y, Krishna Kumar K, Jiang Q, Appourchaux K, Huang W, Zhang C, Kennedy BJ, Mathiesen JM, Che T, McLaughlin JP, Majumdar S, Kobilka BK: A µ-opioid receptor modulator that works cooperatively with naloxone. In: Nature. 631. Jahrgang, Nr. 8021, 2024, S. 686–693, doi:10.1038/s41586-024-07587-7, PMID 38961287.
  • Beispiel: Kaneko S, Imai S, Uchikubo-Kamo T, Hisano T, Asao N, Shirouzu M, Shimada I: Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator. In: Nat Commun. 15. Jahrgang, Nr. 1, 2024, S. 3544, doi:10.1038/s41467-024-47792-6, PMID 38740791, PMC 11091225 (freier Volltext).
  • Piltonen M, Krokhotin A, Parisien M, Bérubé P, Djambazian H, Sladek R, Dokholyan NV, Shabalina SA, Diatchenko L: Alternative Splicing of Opioid Receptor Genes Shows a Conserved Pattern for 6TM Receptor Variants. In: Cell Mol Neurobiol. 41. Jahrgang, Nr. 5, 2021, S. 1039–1055, doi:10.1007/s10571-020-00971-7, PMID 33010019, PMC 8159799 (freier Volltext).
  • Piltonen M, Parisien M, Grégoire S, Chabot-Doré AJ, Jafarnejad SM, Bérubé P, Djambazian H, Sladek R, Geneau G, Willett P, Stone LS, Shabalina SA, Diatchenko L: Alternative Splicing of the Delta-Opioid Receptor Gene Suggests Existence of New Functional Isoforms. In: Mol Neurobiol. 56. Jahrgang, Nr. 4, 2019, S. 2855–2869, doi:10.1007/s12035-018-1253-z, PMID 30066306.
  • Ugur M, Derouiche L, Massotte D: Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo. In: Front Pharmacol. 9. Jahrgang, 2018, S. 1240, doi:10.3389/fphar.2018.01240, PMID 30483121, PMC 6244869 (freier Volltext).
  • Zhang L, Zhang JT, Hang L, Liu T: Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective. In: Front Pharmacol. 11. Jahrgang, 2020, S. 1078, doi:10.3389/fphar.2020.01078, PMID 32760281, PMC 7373791 (freier Volltext).
  • Gaborit M, Massotte D: Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities. In: Br J Pharmacol. 180. Jahrgang, Nr. 7, 2023, S. 994–1013, doi:10.1111/bph.15772, PMID 34883528.
  • Cechova K, Lan C, Macik M, Barthes NPF, Jung M, Ulbrich MH: Kappa but not delta or mu opioid receptors form homodimers at low membrane densities. In: Cell Mol Life Sci. 78. Jahrgang, Nr. 23, 2021, S. 7557–7568, doi:10.1007/s00018-021-03963-y, PMID 34657173, PMC 8629795 (freier Volltext).
  • Li-Wei C, Can G, De-He Z, Qiang W, Xue-Jun X, Jie C, Zhi-Qiang C: Homodimerization of human mu-opioid receptor overexpressed in Sf9 insect cells. In: Protein Pept Lett. 9. Jahrgang, Nr. 2, 2002, S. 145–52, doi:10.2174/0929866023408850, PMID 12141912.
  • Fujita W, Gomes I, Devi LA: Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities. In: Br J Pharmacol. 172. Jahrgang, Nr. 2, 2015, S. 375–87, doi:10.1111/bph.12663, PMID 24571499, PMC 4292954 (freier Volltext).
  • Costantino CM, Gomes I, Stockton SD, Lim MP, Devi LA: Opioid receptor heteromers in analgesia. In: Expert Rev Mol Med. 14. Jahrgang, 2012, S. e9, doi:10.1017/erm.2012.5, PMID 22490239, PMC 3805500 (freier Volltext).
  • Remesic M, Hruby VJ, Porreca F, Lee YS: Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. In: ACS Chem Neurosci. 8. Jahrgang, Nr. 6, 2017, S. 1147–1158, doi:10.1021/acschemneuro.7b00090, PMID 28368571, PMC 5689070 (freier Volltext).
  • Han J, Zhang J, Nazarova AL, Bernhard SM, Krumm BE, Zhao L, Lam JH, Rangari VA, Majumdar S, Nichols DE, Katritch V, Yuan P, Fay JF, Che T: Ligand and G-protein selectivity in the κ-opioid receptor. In: Nature. 617. Jahrgang, Nr. 7960, 2023, S. 417–425, doi:10.1038/s41586-023-06030-7, PMID 37138078, PMC 10172140 (freier Volltext).
  • Lamberts JT, Jutkiewicz EM, Mortensen RM, Traynor JR: μ-Opioid receptor coupling to Gα(o) plays an important role in opioid antinociception. In: Neuropsychopharmacology. 36. Jahrgang, Nr. 10, 2011, S. 2041–53, doi:10.1038/npp.2011.91, PMID 21654736, PMC 3158321 (freier Volltext).